These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Role of glucagon, catecholamines, and growth hormone in human glucose counterregulation. Effects of somatostatin and combined alpha- and beta-adrenergic blockade on plasma glucose recovery and glucose flux rates after insulin-induced hypoglycemia. Rizza RA, Cryer PE, Gerich JE. J Clin Invest; 1979 Jul; 64(1):62-71. PubMed ID: 36413 [Abstract] [Full Text] [Related]
5. An in vivo and in vitro study of the mechanism of prednisone-induced insulin resistance in healthy subjects. Pagano G, Cavallo-Perin P, Cassader M, Bruno A, Ozzello A, Masciola P, Dall'omo AM, Imbimbo B. J Clin Invest; 1983 Nov; 72(5):1814-20. PubMed ID: 6355186 [Abstract] [Full Text] [Related]
7. Evidence for an important role of glucagon in the regulation of hepatic glucose production in normal man. Liljenquist JE, Mueller GL, Cherrington AD, Keller U, Chiasson J-L, Perry JM, Lacy WW, Rabinowitz D. J Clin Invest; 1977 Feb; 59(2):369-74. PubMed ID: 833282 [Abstract] [Full Text] [Related]
11. Effect of ketone bodies on glucose production and utilization in the miniature pig. Müller MJ, Paschen U, Seitz HJ. J Clin Invest; 1984 Jul; 74(1):249-61. PubMed ID: 6376544 [Abstract] [Full Text] [Related]
15. Effects of glucocorticoids on hepatic sensitivity to insulin and glucagon in man. Dirlewanger M, Schneiter PH, Paquot N, Jequier E, Rey V, Tappy L. Clin Nutr; 2000 Feb; 19(1):29-34. PubMed ID: 10700531 [Abstract] [Full Text] [Related]
17. FK-614, a selective peroxisome proliferator-activated receptor gamma agonist, improves peripheral glucose utilization while decreasing hepatic insulin extraction in alloxan-induced diabetic dogs. Uchino H, Kim T, Lam TK, Yoshii H, Klement P, Williams W, Kawamori R, Giacca A. Metabolism; 2005 Sep; 54(9):1250-8. PubMed ID: 16125538 [Abstract] [Full Text] [Related]
18. Dopamine during alpha- or beta-adrenergic blockade in man. Hormonal, metabolic, and cardiovascular effects. Lorenzi M, Karam JH, Tsalikian E, Bohannon NV, Gerich JE, Forsham PH. J Clin Invest; 1979 Feb; 63(2):310-7. PubMed ID: 34629 [Abstract] [Full Text] [Related]